Rare diseases
Investigational molecules
Locations
Seminarstrasse 2, Altstadt, 69117 Heidelberg, Germany
Heidelberg University supports clinical research in advanced solid tumours, with a strong focus on non-small-cell lung cancer and adenocarcinoma of the gastroesophageal junction. Its funded studies address treatment selection in stage IV NSCLC with atypical EGFR mutations and perioperative strategies for resectable upper gastrointestinal cancer.
The oncology portfolio also includes treatment planning around surgical outcomes, progression-free survival, and disease control in locally advanced digestive tract malignancies.
Heidelberg University runs clinical trials in conditions such as Non-small cell lung cancer stage IV, Intracranial aneurysm, Chronic myeloid leukaemia (in remission), Philadelphia positive chronic myeloid leukaemia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Germany
FinlandGermanyGermanyGermanyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
